$LQDA

Krepp Sarah sold $17K of LQDA

Krepp Sarah (Chief Human Resource Officer) sold 276 shares of Liquidia Corp (LQDA) at $60.87 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Krepp Sarah
Published Jun 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LQDA
Neutral
high confidence
Mentioned
$LQDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (shares, price, total value) and confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 designation and small dollar amount reduce expected market impact.

03

What to watch

The disclosure does not indicate intent beyond the pre-arranged plan, and the sale size ($16.8k) is small relative to typical institutional trading flows.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-03, disclosing a 2026-06-01 insider sale.

Background

The article is an SEC Form 4 insider transaction filing for Liquidia Corp, reported by an officer (Chief Human Resource Officer).

Company-level read

Ticker impact

$LQDANeutralHigh confidence
Context

Liquidia insider Krepp Sarah, Chief Human Resource Officer, sold 276 shares at $60.87 on 2026-06-01 under a 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely muted given the stated 10b5-1 pre-arranged plan.

Evidence & confidence

Form 4 reports an open-market sale with a pre-arranged 10b5-1 plan, providing no new company fundamentals or guidance in the text.

Market effects

No sector-level implications; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, some traders may interpret insider selling as a signal of reduced confidence, especially if multiple insiders sell around the same period.

Key entities

  • Liquidia Corp

    US-listed company subject of the Form 4 insider transaction disclosure.

  • Krepp Sarah

    Chief Human Resource Officer who sold 276 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LQDAMed

Liquidia Jumps 6.3% After HC Wainwright & Co. Maintains Buy

Liquidia Corporation (LQDA) rose 6.3% to $36.27 after four firms raised price targets, with an average of $57. HC Wainwright & Co. maintained a Buy rating, lifting its target to $65. The upgrades reflect optimism about the company's prospects and pipeline potential, with a 29.0% average target increase. LQDA's market cap is $3.2B.

$LQDAMedAI 8/10

Morrisville’s Liquidia Settles All Litigation With United Therapeutics, Keeping YUTREPIA Available for PAH Patients

Liquidia Corporation settled all litigation with United Therapeutics, resolving six lawsuits. The agreement allows YUTREPIA, a treatment for pulmonary arterial hypertension, to remain available. Liquidia will pay $380.7 million across 2026 and 2027, funded by YUTREPIA sales and cash on hand. The company reported $222.7 million in YUTREPIA net sales for Q3 2026 and has $396.1 million in cash.

$LQDAMed

H.C. Wainwright raises Liquidia stock price target on settlement

H.C. Wainwright raised its price target for Liquidia Technologies (LQDA) to $65 from $58, maintaining a Buy rating. The stock has surged 21% over the past week following a settlement with United Therapeutics, resolving all pending lawsuits. The settlement removes litigation overhang and allows Liquidia to focus on its pipeline. Analysts have mixed outlooks on the company's future performance.